Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2010-02-28

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-center study to assess the diagnostic accuracy of the Troponin I assay in the Biosite Triage Cardio3 Panel at the point-of-care (POC) in adults presenting to the emergency department with possible acute myocardial infarction (AMI).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes

NCT00222352

Angina, Unstable

COMPLETED

Evaluation of a New Cardiac Biomarker Assay

NCT01608100

Acute Coronary Syndrome Acute Myocardial Infarction

COMPLETED PHASE3

Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway

NCT05322395

Acute Coronary Syndrome Troponin Chest Pain +1 more

RECRUITING NA

Cardiology-Emergency Medicine Cardiac Biomarker Research Initiative

NCT01984853

Acute Coronary Syndrome

COMPLETED

Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department

NCT06899776

ACS (Acute Coronary Syndrome)

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Myocardial Infarction Chest Pain Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older at time of enrollment
* Presenting to the ED within 6 hours from onset of chest discomfort (pain, pressure, tightness, etc) consistent with a possible diagnosis of AMI or ACS and with an initial ECG non-diagnostic for injury (or injury equivalent resulting in emergent reperfusion therapy). (NOTE: Subjects who have chest discomfort that is episodic or stuttering in nature may be included if the ED presentation is within 6 hours of symptom onset.)
* Experiencing at least 30 minutes of chest pain or other anginal equivalent symptoms. (Note: Subjects who have symptoms of shorter duration due to pharmacologic intervention may be included.)

Exclusion Criteria

* Patient (or Legal Representative) unable or unwilling to provide written informed consent.
* Patient unwilling or unlikely to comply with study procedures, including protocol-specified blood sampling or telephone follow-up at 30 days and 6 months.
* Vulnerable populations as deemed inappropriate for study by site principal investigator.
* ST-elevation or other ECG criteria that result that is diagnostic for AMI and results in patient being sent for percutaneous coronary interventions (PCI) or being treated with thrombolytics6.
* Pulmonary Edema requiring CPAP, BIPAP, or mechanical ventilation
* Tachyarrhythmias (SVT, V-Tach, rapid atrial fib)
* End Stage Renal Disease on Hemodialysis
* Cardiac Arrest prior to arrival
* Implantable Defibrillator firing prior to arrival
* Hemodynamically unstable patients
* Trauma injury to the chest

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No